A high-yield exam and history clues can help clinicians spot eyelid lesions that shouldn't be dismissed.
Video Highlights
A practical framework for differentiating common benign eyelid lesions from ones that may require biopsy or closer evaluation, with emphasis on day-to-day clinical recognition.
Four exam findings that should raise suspicion for malignancy: ulceration, madarosis (loss of eyelashes), asymmetry or irregular borders and telangiectatic vessels.
For epidermal malignancies, basal cell carcinoma is the most common eyelid skin cancer, while squamous cell carcinoma is less common but may be more invasive.
Sebaceous cell carcinoma is a major diagnostic pitfall because it can mimic chronic blepharitis or a persistent chalazion and may require biopsy when standard therapy fails.
Stable nevi with lashes growing through them may be observed, whereas growth, lash loss, irregular pigmentation or poorly defined borders should prompt concern for melanoma.
In this whiteboard overview, Dr. Amina Malik, associate professor of ophthalmology and director of oculoplastic surgery at Houston Methodist Hospital, reviews the most common eyelid lesions clinicians may encounter and explains how to distinguish benign presentations from potentially malignant lesions. Her core message is clinical vigilance: benign lesions such as seborrheic keratosis, skin tags, chalazia, epidermal inclusion cysts, milia, xanthelasma and many nevi can often be observed or managed conservatively, but suspicious features on history and exam should shift the clinician toward biopsy. Dr. Malik particularly emphasizes the importance of not missing basal cell carcinoma, squamous cell carcinoma, sebaceous cell carcinoma or melanoma, especially when lesions are ulcerated, irregular, destructive to lashes, vascular, growing or not responding to standard treatment.